Vroman Ken 4

What Happened Ken Vroman, Chief Transformation Officer of CME Group (CME), received a vesting award of 7,076 performance shares on 2026-03-15 at a reported value of $311.40 per share (total value $2,203,466). To satisfy tax withholding related to the award, 3,135 of those shares were surrendered to the company at the same price, representing $976,239. After withholding, Vroman’s net increase from this vesting event was 3,941 shares (approximately $1,227,227 at $311.40).

Key Details

• Transaction date(s): 2026-03-15
  • Award/acquisition (A): 7,076 shares @ $311.40 = $2,203,466
  • Tax withholding/disposition (F): 3,135 shares @ $311.40 = $976,239
• Net shares retained from vesting: 3,941 shares (net value ≈ $1.23M)
• Shares owned after transaction: Not disclosed in the provided filing
• Footnotes:
  • F1: Vesting of performance shares granted in 2022 under the Omnibus Stock Plan; payout based on CME’s total shareholder return vs. the S&P 500 for 1/1/2023–12/31/2025.
  • F2: Shares were surrendered to the company to satisfy tax withholding obligations (routine).
• Filing timeliness: Form 4 filed on 2026-03-17 reporting transactions dated 2026-03-15 (filed within the standard two-business-day window).

Context This was a vesting of performance-based restricted shares, not an open-market purchase or option exercise. The surrender of shares to cover taxes is a common, administrative step and does not by itself indicate a change in insider sentiment. The number of shares delivered was determined by achievement versus a multi-year TSR goal relative to the S&P 500.